UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

UK guidelines for the management of soft tissue sarcomas

British journal of cancer, 2024-05

2024

Volltextzugriff (PDF)

Technical development and validation of a clinically applicable microenvironment classifier as a biomarker of tumour hypoxia for soft tissue sarcoma

British journal of cancer, 2023-06, Vol.128 (12), p.2307-2317

2023

Volltextzugriff (PDF)

Axitinib in patients with advanced/metastatic soft tissue sarcoma (Axi-STS): an open-label, multicentre, phase II trial in four histological strata

British journal of cancer, 2023-10, Vol.129 (9), p.1490-1499

2023

Volltextzugriff (PDF)

Significant Clinical Benefit of First-Line Palliative Chemotherapy in Advanced Soft-Tissue Sarcoma : Retrospective Analysis and Identification of Prognostic Factors in 488 Patients

Cancer, 2008-04, Vol.112 (7), p.1585-1591

2008

Volltextzugriff (PDF)

Best clinical management of tenosynovial giant cell tumour (TGCT): A consensus paper from the community of experts

Cancer treatment reviews, 2023-01, Vol.112, p.102491, Article 102491

2023

Volltextzugriff (PDF)

Early results and volumetric analysis after spot-scanning proton therapy with concomitant hyperthermia in large inoperable sacral chordomas

British journal of radiology, 2020-03, Vol.93 (1107), p.20180883-20180883

2020

Volltextzugriff (PDF)

Uterine sarcomas—Recent progress and future challenges

European journal of radiology, 2011-04, Vol.78 (1), p.30-40

2011

Volltextzugriff (PDF)

Follow-up practices for high-grade extremity Osteosarcoma

BMC cancer, 2016-05, Vol.16 (300), p.301-301, Article 301

2016

Volltextzugriff (PDF)

A Phase I Study of SR-4554 via Intravenous Administration for Noninvasive Investigation of Tumor Hypoxia by Magnetic Resonance Spectroscopy in Patients with Malignancy

Clinical cancer research, 2003-11, Vol.9 (14), p.5101-5112

2003

Volltextzugriff (PDF)

Validation of the Fluorinated 2-Nitroimidazole SR-4554 as a Noninvasive Hypoxia Marker Detected by Magnetic Resonance Spectroscopy

Clinical cancer research, 2002-07, Vol.8 (7), p.2323-2335

2002

Volltextzugriff (PDF)

Emerging Chemotherapeutic Strategies and the Role of Treatment Stratification in Ewing Sarcoma

Paediatric drugs, 2008, Vol.10 (2), p.93-105

2008

Volltextzugriff (PDF)

Clinical outcome in patients with peripherally‐sited atypical lipomatous tumours and dedifferentiated liposarcoma

The journal of pathology. Clinical research, 2015-04, Vol.1 (2), p.106-112

2015

Volltextzugriff (PDF)

Measurement of Tumor Oxygenation: In Vivo Comparison of a Luminescence Fiber-optic Sensor and a Polarographic Electrode in the P22 Tumor

Radiation research, 2001-06, Vol.155 (6), p.837-846

2001

Volltextzugriff (PDF)

Significant clinical benefit of first‐line palliative chemotherapy in advanced soft‐tissue sarcoma

Cancer, 2008-04, Vol.112 (7), p.1585-1591

2008

Volltextzugriff (PDF)

Radiotherapy for Management of Extremity Soft Tissue Sarcomas: Why, When, and Where?

International journal of radiation oncology, biology, physics, 2012-11, Vol.84 (3), p.572-580

2012

Volltextzugriff (PDF)

Uterine sarcomas—Recent progress and future challenges : Imaging diseases of the female pelvis SI

European journal of radiology, 2011, Vol.78 (1), p.30-40

2011

Volltextzugriff (PDF)

Activity of cediranib in alveolar soft part sarcoma (ASPS) confirmed by CASPS (cediranib in ASPS), an international, randomised phase II trial (C2130/A12118)

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.11004-11004

2017

Volltextzugriff (PDF)

Imatinib mesylate (IM) activity in patients (pts) with locally advanced tenosynovial giant cell tumor/pigmented villonodular synovitis (TGCT)

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.10561-10561

2015

Volltextzugriff (PDF)

GeDDiS: A prospective randomised controlled phase III trial of gemcitabine and docetaxel compared with doxorubicin as first-line treatment in previously untreated advanced unresectable or metastatic soft tissue sarcomas (EudraCT 2009-014907-29)

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.10500-10500

2015

Volltextzugriff (PDF)

Regorafenib treatment for advanced, refractory gastrointestinal stromal tumor: A report of the U.K. Managed Access Program

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.10551-10551

2014

Volltextzugriff (PDF)

Can postoperative radiotherapy be omitted in localized standard-risk Ewing sarcoma? An observational study of the Euro-EWING Group

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.10518-10518

2013

Volltextzugriff (PDF)

Fatal Radiation Myelopathy After High-dose Busulfan and Melphalan Chemotherapy and Radiotherapy for Ewing's Sarcoma: A Review of the Literature and Implications for Practice

Clinical oncology (Royal College of Radiologists (Great Britain)), 2005-08, Vol.17 (5), p.385-390

2005

Volltextzugriff (PDF)

Automated high pressure cell for pressure jump x-ray diffraction

Review of scientific instruments, 2010-06, Vol.81 (6), p.064103-064103-10

2010

Volltextzugriff (PDF)

Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial

Journal of clinical oncology, 2015-07, Vol.33 (20), p.2279-2287

2015

Volltextzugriff (PDF)

Cediranib in patients with alveolar soft-part sarcoma (CASPS): a double-blind, placebo-controlled, randomised, phase 2 trial

The lancet oncology, 2019-07, Vol.20 (7), p.1023-1034

2019

Volltextzugriff (PDF)

1 – 25 von 33

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(33)
Mit Volltextzugriff
(30)

Publikationsform

Artikel
(33)

Sprache

Englisch
(33)

Erscheinungsjahr

n.n

Thema

Science & Technology
(24)
Life Sciences & Biomedicine
(22)
Humans
(19)
Oncology
(16)
Female
(12)
Tumors
(11)
Male
(10)
Aged
(8)
Adult
(7)
Middle Aged
(7)
Biological And Medical Sciences
(6)
Medical Sciences
(6)
Prognosis
(6)
Radiology, Nuclear Medicine & Medical Imaging
(6)
Sarcoma
(6)
Adolescent
(5)
Chemotherapy
(5)
Metastasis
(5)
Follow-Up Studies
(4)
Patients
(4)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

UK guidelines for the management of soft tissue sarcomas

Technical development and validation of a clinically applicable microenvironment classifier as a biomarker of tumour hypoxia for soft tissue sarcoma

Axitinib in patients with advanced/metastatic soft tissue sarcoma (Axi-STS): an open-label, multicentre, phase II trial in four histological strata

Significant Clinical Benefit of First-Line Palliative Chemotherapy in Advanced Soft-Tissue Sarcoma : Retrospective Analysis and Identification of Prognostic Factors in 488 Patients

Best clinical management of tenosynovial giant cell tumour (TGCT): A consensus paper from the community of experts

Early results and volumetric analysis after spot-scanning proton therapy with concomitant hyperthermia in large inoperable sacral chordomas

Uterine sarcomas—Recent progress and future challenges

Follow-up practices for high-grade extremity Osteosarcoma

A Phase I Study of SR-4554 via Intravenous Administration for Noninvasive Investigation of Tumor Hypoxia by Magnetic Resonance Spectroscopy in Patients with Malignancy

Validation of the Fluorinated 2-Nitroimidazole SR-4554 as a Noninvasive Hypoxia Marker Detected by Magnetic Resonance Spectroscopy

Emerging Chemotherapeutic Strategies and the Role of Treatment Stratification in Ewing Sarcoma

Clinical outcome in patients with peripherally‐sited atypical lipomatous tumours and dedifferentiated liposarcoma

Measurement of Tumor Oxygenation: In Vivo Comparison of a Luminescence Fiber-optic Sensor and a Polarographic Electrode in the P22 Tumor

Significant clinical benefit of first‐line palliative chemotherapy in advanced soft‐tissue sarcoma

Radiotherapy for Management of Extremity Soft Tissue Sarcomas: Why, When, and Where?

Uterine sarcomas—Recent progress and future challenges : Imaging diseases of the female pelvis SI

Activity of cediranib in alveolar soft part sarcoma (ASPS) confirmed by CASPS (cediranib in ASPS), an international, randomised phase II trial (C2130/A12118)

Imatinib mesylate (IM) activity in patients (pts) with locally advanced tenosynovial giant cell tumor/pigmented villonodular synovitis (TGCT)

GeDDiS: A prospective randomised controlled phase III trial of gemcitabine and docetaxel compared with doxorubicin as first-line treatment in previously untreated advanced unresectable or metastatic soft tissue sarcomas (EudraCT 2009-014907-29)

Regorafenib treatment for advanced, refractory gastrointestinal stromal tumor: A report of the U.K. Managed Access Program

Can postoperative radiotherapy be omitted in localized standard-risk Ewing sarcoma? An observational study of the Euro-EWING Group

Fatal Radiation Myelopathy After High-dose Busulfan and Melphalan Chemotherapy and Radiotherapy for Ewing's Sarcoma: A Review of the Literature and Implications for Practice

Automated high pressure cell for pressure jump x-ray diffraction

Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial

Cediranib in patients with alveolar soft-part sarcoma (CASPS): a double-blind, placebo-controlled, randomised, phase 2 trial

Suchergebnisse filtern